Epigenetic Homogeneity Within Colorectal Tumors Predicts Shorter Relapse-Free and Overall Survival Times for Patients With Locoregional Cancer.

Anna Martínez-Cardús , Sebastian Moran , Eva Musulen , Cátia Moutinho
Gastroenterology 151 ( 5) 961 -972

28
2016
Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy.

Marc Castellví , Eudald Felip , Ifeanyi Ezeonwumelu , Roger Badia
Cancers 12 ( 3) 713

3
2020
Soluble FAS in the prediction of benefit from cetuximab and irinotecan for patients with advanced colorectal cancer.

Jordi Codony-Servat , Xabier Garcia-Albeniz , Carles Pericay , Vicente Alonso
Medical Oncology 30 ( 1) 428

3
2013
Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer

Alexander Kel , Ulyana Boyarskikh , Philip Stegmaier , Leonid S. Leskov
BMC Bioinformatics 20 ( S4) 119

9
2019
PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines

Alba Ginés , Sara Bystrup , Vicenç Ruiz de Porras , Cristina Guardia
PLOS ONE 10 ( 5) e0123830

21
2015
Epigenetic EGFR Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas.

Jaume Capdevila , Oriol Arqués , Jose Ramón Hernández Mora , Judit Matito
Clinical Cancer Research 26 ( 4) 902 -909

5
2020
Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis

Michäel Duruisseaux , Anna Martínez-Cardús , Maria E Calleja-Cervantes , Sebastian Moran
The Lancet Respiratory Medicine 6 ( 10) 771 -781

2018
SAMHD1 expression modulates innate immune activation and correlates with ovarian cancer prognosis

Lucía Gutiérrez-Chamorro , Eudald Felip , Adrià Bernat-Peguera , Ifeanyi Jude Ezeonwumelu
Frontiers in immunology 14 1112761 -1112761

2
2023
SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer

Lucía Gutiérrez-Chamorro , Eudald Felip , Eva Castellà , Vanessa Quiroga
Cellular Oncology 47 ( 1) 189 -208

2024
Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis.

Carmen Anadón , Sonia Guil , Laia Simó-Riudalbas , Catia Moutinho
Oncogene 35 ( 33) 4407 -4413

88
2016
DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia

Humberto J Ferreira , Holger Heyn , Miguel Vizoso , Cátia Moutinho
Oncogene 35 ( 23) 3079 -3082

37
2016
Epigenetic loss of the RNA decapping enzyme NUDT16 mediates C-MYC activation in T-cell acute lymphoblastic leukemia

Carmen Anadón , Geert van Tetering , Humberto J Ferreira , Catia Moutinho
Leukemia 31 ( 7) 1622 -1625

17
2017
Immunotherapy Resumption/Rechallenge in Melanoma Patients after Toxicity: Do We Have Another Chance?

Sofia España Fernandez , Chen Sun , Carme Solé-Blanch , Aram Boada
Pharmaceutics 15 ( 3) 823 -823

2
2023
HLA-I levels correlate with survival outcomes in response to immune checkpoint inhibitors in non-small cell lung cancer

Maria Saigí , Jose L Mate , Enric Carcereny , Anna Martínez-Cardús
Lung Cancer 189 107502 -107502

1
2024
Exploring HER2-low disease: Does it impact breast cancer survival?

Assumpció López-Paradís , Anna Pous , Adrià Bernat-Peguera , Vanesa Quiroga
Journal of Clinical Oncology 41 ( 16_suppl) 577 -577

2023
Epigenetic EGFR gene repression confers colon neuroendocrine carcinomas sensitivity to therapeutic BRAFV600E blockade

Jaume Capdevila , Oriol Arqués , Jose Ramón Hernández , Judit Matito
Clinical Cancer Research

2020
PKM2 subcellular localization is involved in oxaliplatin resistance acquisition in human colorectal cancer cell lines

Alba Ginés , Anna Martínez-Cardús , Vicenç Ruiz de Porras , Eva Musulén
Cancer Research 74 ( 19_Supplement) 3752 -3752

2014